startup
/dev/fastdev.fast
/dev/fast is an AI-powered platform that generates and optimizes code for developers.
- 机会评分
- 80 / 100
- 累计融资
- unknown
- 融资阶段
- unknown
- 成立年份
- 2026
- 地区
- Global
- 阶段
- pre-seed
八个维度
Company · Problem · Solution · Target Customer · Business Model · Funding · Competitors · Why NowCompany
/dev/fast is a Y Combinator-backed startup focused on creating an AI-native code generation platform. The company aims to help developers write better code faster by leveraging AI.
Problem
Modern software development is time-consuming, error-prone, and often requires developers to reinvent the wheel. This leads to inefficiencies, bugs, and slower time-to-market.
Solution
/dev/fast provides an AI-powered platform that generates, optimizes, and suggests code snippets. The tool integrates with existing development workflows to enhance productivity.
Target Customer
The target customers are software developers, engineering teams, and tech companies. The primary paying方 is the development or engineering department of these organizations.
Business Model
/dev/fast plans to monetize through a subscription-based model, with additional revenue from premium features and enterprise solutions.
Funding
该维度暂无可核实信息(unknown)
Competitors
Direct competitors include GitHub Copilot, TabNine, and other AI-powered code assistants. Indirect competitors include traditional IDEs and development tools.
Why Now
The growing adoption of AI in software development, coupled with the need for increased productivity, makes this the right time for /dev/fast to enter the market.
来源与 AI 标注
模型 · prompt 版本 · 生成时间 · 来源链接相关项目与同赛道
按赛道继续看相关项目6 家
| 公司 | 赛道 | 评分 |
|---|---|---|
| ReboltAI驱动的企业操作系统 | AIB2B企业服务 | 95 |
| EliseAIAI-driven platform for enterprise efficiency and decision-making | AISaaS | 90 |
| TensorTestAI-powered creative task evaluation platform | AIB2BData | 90 |
| LucentAI that automatically improves products from user behavior. | B2BAIProductivity | 90 |
| Paratus HealthAI 驱动的医疗数据分析平台 | HealthcareAI | 90 |
| HealthKeyAI-Powered Patient Matching for Clinical Trials | AIHealthcareClinical Trials | 90 |
同赛道入口按赛道继续看
数据来自公开渠道与 AI 解读,仅供参考,不构成投资建议。信息可能滞后或有误,决策请以公司官网与官方披露为准。